0001808805-22-000037.txt : 20220415
0001808805-22-000037.hdr.sgml : 20220415
20220415170721
ACCESSION NUMBER: 0001808805-22-000037
CONFORMED SUBMISSION TYPE: 3/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220411
FILED AS OF DATE: 20220415
DATE AS OF CHANGE: 20220415
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Weld Gwen E
CENTRAL INDEX KEY: 0001378831
FILING VALUES:
FORM TYPE: 3/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39434
FILM NUMBER: 22830562
MAIL ADDRESS:
STREET 1: C/O ISILON SYSTEMS, INC.
STREET 2: 3101 WESTERN AVENUE
CITY: SEATTLE
STATE: WA
ZIP: 98121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nautilus Biotechnology, Inc.
CENTRAL INDEX KEY: 0001808805
STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY ANALYTICAL INSTRUMENTS [3826]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2701 EASTLAKE AVE EAST
CITY: SEATTLE
STATE: WA
ZIP: 98102
BUSINESS PHONE: 206-333-2001
MAIL ADDRESS:
STREET 1: 2701 EASTLAKE AVE EAST
CITY: SEATTLE
STATE: WA
ZIP: 98102
FORMER COMPANY:
FORMER CONFORMED NAME: ARYA Sciences Acquisition Corp III
DATE OF NAME CHANGE: 20200408
3/A
1
wf-form3a_165005682403411.xml
FORM 3/A
X0206
3/A
2022-04-11
2022-04-13
0
0001808805
Nautilus Biotechnology, Inc.
NAUT
0001378831
Weld Gwen E
C/O NAUTILUS BIOTECHNOLOGY, INC.
2701 EASTLAKE AVENUE EAST
SEATTLE
WA
98102
0
1
0
0
Chief People Officer
Stock Option (Right to Buy)
1.14
2030-10-15
Common Stock
4535.0
D
Subject to reporting person's continuous status as a "Service Provider" (as defined in the Nautilus Subsidiary, Inc. 2017 Equity Incentive Plan (the "Plan")) through each vesting date, one twenty-fourth (1/24th) of the shares subject to the Option shall vest each month over the twenty-four (24) months following the Vesting Commencement Date (as defined below) on the same day of the month as the Vesting Commencement Date (and if there is no corresponding day, on the last day of the month). The Vesting Commencement Date is September 29, 2020.
Form 3 amended to reflect stock option held by reporting person.
/s/ Matthew B. Murphy, as Attorney-in-Fact
2022-04-15